Today in focus: Valneva
Valneva’s stock has risen in recent days on positive vaccine data. The latest study results from Valneva look promising: according to these results, the Covid-19 vaccine from the French-Austrian company showed better immune protection than that from Astra-Zeneca in a clinical phase 3 study with more than 4000 participants. In addition, subjects 30 years of…